Matches in Wikidata for { <http://www.wikidata.org/entity/Q73330861> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q73330861 description "article scientifique publié en 2003" @default.
- Q73330861 description "artículu científicu espublizáu en mayu de 2003" @default.
- Q73330861 description "im Mai 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73330861 description "scientific article published on 01 May 2003" @default.
- Q73330861 description "wetenschappelijk artikel" @default.
- Q73330861 description "наукова стаття, опублікована в травні 2003" @default.
- Q73330861 name "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 name "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 type Item @default.
- Q73330861 label "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 label "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 prefLabel "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 prefLabel "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 P1433 Q73330861-20AEBD16-E8E8-4886-A205-3595A1458D19 @default.
- Q73330861 P1476 Q73330861-91A38AA6-26CE-4AC4-A9AE-930F379DD7E9 @default.
- Q73330861 P2093 Q73330861-2A52BF62-EBD3-4156-8CE1-EDAD56545F19 @default.
- Q73330861 P2093 Q73330861-38A3B3B1-255A-421E-987D-72B4B3D60970 @default.
- Q73330861 P2093 Q73330861-5741F284-EA27-44BC-808C-8256B5F275B1 @default.
- Q73330861 P2093 Q73330861-8AECD2EA-AF5A-489A-88C7-7AD77FD8985D @default.
- Q73330861 P2093 Q73330861-AA97DB67-02B5-4273-BDDD-AFF0E1AD5315 @default.
- Q73330861 P2093 Q73330861-BBF97DCB-A38A-4B6E-95BF-B55476DF6354 @default.
- Q73330861 P2093 Q73330861-C95F80D1-D580-42B0-B6B1-66C4D29F4A77 @default.
- Q73330861 P2093 Q73330861-D5998043-946E-4A34-B0D5-7BADCB450CB7 @default.
- Q73330861 P2093 Q73330861-F91CCF37-2561-4413-9FA4-53FF6671B675 @default.
- Q73330861 P304 Q73330861-E5157940-15C6-4BE8-A740-FE6D912086AB @default.
- Q73330861 P31 Q73330861-869C7D0B-8F35-4BB8-AA39-75C0E6FAF456 @default.
- Q73330861 P356 Q73330861-3299CC3B-09A8-43A1-BE23-CF404CD42285 @default.
- Q73330861 P407 Q73330861-3F75A66A-F566-47CA-B1A9-970FFD3DECD8 @default.
- Q73330861 P433 Q73330861-15A6AD10-384B-4C1C-9CFB-9EE72D8DEC81 @default.
- Q73330861 P478 Q73330861-23E903AE-F8CA-476F-B049-64C0EEDD756E @default.
- Q73330861 P50 Q73330861-0B18F0FD-B171-4670-8AB8-D4800B633292 @default.
- Q73330861 P50 Q73330861-0D51DB89-F030-473B-86E7-6318309A9744 @default.
- Q73330861 P50 Q73330861-3CA2C81D-BB84-423D-B008-489804EF0C41 @default.
- Q73330861 P50 Q73330861-DBF4EB45-4A12-469E-8E77-A0317AEE5A86 @default.
- Q73330861 P577 Q73330861-7ACE8442-A4B4-4F50-B289-EB11EAD0A5EC @default.
- Q73330861 P698 Q73330861-D8F8121B-12CB-43CF-825A-26E0012FDBB5 @default.
- Q73330861 P921 Q73330861-2BA8CB14-E68D-4203-ADA9-6241511BB486 @default.
- Q73330861 P921 Q73330861-B96B23CF-85D3-4E95-8A7E-BF4811A38B47 @default.
- Q73330861 P356 JCO.2003.04.033 @default.
- Q73330861 P698 12721248 @default.
- Q73330861 P1433 Q400292 @default.
- Q73330861 P1476 "Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM" @default.
- Q73330861 P2093 "Christine M Segeren" @default.
- Q73330861 P2093 "Dutch-Belgian Hemato-Oncology Cooperative Group" @default.
- Q73330861 P2093 "Jan J Cornelissen" @default.
- Q73330861 P2093 "Leo F Verdonck" @default.
- Q73330861 P2093 "Marinus H J van Oers" @default.
- Q73330861 P2093 "Monique M C Steijaert" @default.
- Q73330861 P2093 "Petra H M Westveer" @default.
- Q73330861 P2093 "Reinier Raymakers" @default.
- Q73330861 P2093 "Renee M Y Barge" @default.
- Q73330861 P304 "1728-1733" @default.
- Q73330861 P31 Q13442814 @default.
- Q73330861 P356 "10.1200/JCO.2003.04.033" @default.
- Q73330861 P407 Q1860 @default.
- Q73330861 P433 "9" @default.
- Q73330861 P478 "21" @default.
- Q73330861 P50 Q110173595 @default.
- Q73330861 P50 Q110192041 @default.
- Q73330861 P50 Q73546936 @default.
- Q73330861 P50 Q89534570 @default.
- Q73330861 P577 "2003-05-01T00:00:00Z" @default.
- Q73330861 P698 "12721248" @default.
- Q73330861 P921 Q467635 @default.
- Q73330861 P921 Q65592366 @default.